• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄胎常规实践诊断中的挑战:一家三级医疗中心的经验

Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.

作者信息

Lelic Melisa, Fatusic Zlatan, Iljazovic Ermina, Ramic Suada, Markovic Sergije, Alicelebic Selma

机构信息

Medical faculty, University of Tuzla, Tuzla, Bosnia and Herzegovina.

Clinic for Gynecology and Obstetrics, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.

出版信息

Med Arch. 2017 Aug;71(4):256-260. doi: 10.5455/medarh.2017.71.256-260.

DOI:10.5455/medarh.2017.71.256-260
PMID:28974845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5585792/
Abstract

INTRODUCTION

Hydatidiform moles (HM), presenting as complete (CHM) and partial (PHM) form, are rare pregnancy disorder. Diagnosis is based on clinical presentation, ultrasound imaging findings and pathological examination of products of conception. Protein p57, encoded by CKDN1C gene, is paternally imprinted and maternally expressed gene and provides quick insight in genetic basis of HM and allows distinction of CHM from all other conceptions. compare the preevacuational and pathohistological diagnosis with outcome of p57 immunostaining.

MATERIAL AND METHODS

All cases of HM diagnosed between January 2011 and December 2015 were included in this research. Maternal age, gestational age and input diagnosis data were recored. p57 immunostaining was performed in order to evaluate the diagnosis based on tissue slides examination.

RESULTS

There were 198 cases of histologically confirmed HM, 185 PHM, 12 CHM and one case of undefined HM. Mean maternal age in the CHM group was 24,7 and in the PHM group 26,9 years, with no significant differences among these two groups (p=0,27). For CHM mean gestational age was estimated at eight and for PHM 9,2 gestational weeks. Pregnant woman older than 40 years present significant earlier compared with younger woman (p<0,01), and those younger than 20 years tend to present at the beginning of the second trimester more often than older women (p<0,05). In the CHM group, 9 (75%) input diagnoses were mola in obs, and 3 (25%) of them were signed as abortion, unlike the PHM where 126 (67%) were qualified as abortion, 35 (19%) as blighted ovum, and 26 (14%) were suggestive for molar pregnancy. p57 immunostaining results confirmed all pathohistological diagnosis of CHM whereas 8% of PHM demonstrated divergent p57 expression.

CONCLUSION

PHM, compared with CHM, represent a greater diagnostic challenge for both gynecologist and pathologist even when presenting in more advanced pregnancies.

摘要

引言

葡萄胎(HM)表现为完全性(CHM)和部分性(PHM)两种形式,是一种罕见的妊娠疾病。诊断基于临床表现、超声影像学检查结果以及对妊娠产物的病理检查。由CKDN1C基因编码的蛋白质p57是一种父系印记、母系表达的基因,它能快速洞察葡萄胎的遗传基础,并有助于区分完全性葡萄胎与其他所有妊娠情况。比较清宫前诊断和病理组织学诊断与p57免疫染色结果。

材料与方法

本研究纳入了2011年1月至2015年12月期间诊断的所有葡萄胎病例。记录产妇年龄、孕周及初始诊断数据。进行p57免疫染色以基于组织切片检查评估诊断。

结果

共有198例经组织学确诊的葡萄胎,其中185例为部分性葡萄胎,12例为完全性葡萄胎,1例为未明确类型的葡萄胎。完全性葡萄胎组产妇平均年龄为24.7岁,部分性葡萄胎组为26.9岁,两组间无显著差异(p = 0.27)。完全性葡萄胎平均孕周估计为8周,部分性葡萄胎为9.2周。40岁以上孕妇的发病时间明显早于年轻孕妇(p < 0.01),20岁以下孕妇比年长孕妇更倾向于在孕中期开始时发病(p < 0.05)。在完全性葡萄胎组中,初始诊断为产科葡萄胎的有9例(75%),其中3例(25%)诊断为流产,而部分性葡萄胎组中,126例(67%)诊断为流产,35例(19%)诊断为空孕囊,26例(14%)提示为葡萄胎妊娠。p57免疫染色结果证实了所有完全性葡萄胎的病理组织学诊断,而8%的部分性葡萄胎表现出不同的p57表达。

结论

与完全性葡萄胎相比,部分性葡萄胎对妇科医生和病理学家来说都是更大的诊断挑战,即使在妊娠进展到更晚期时也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ec/5585792/c6eb99844ab2/MA-71-256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ec/5585792/c6eb99844ab2/MA-71-256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ec/5585792/c6eb99844ab2/MA-71-256-g001.jpg

相似文献

1
Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.葡萄胎常规实践诊断中的挑战:一家三级医疗中心的经验
Med Arch. 2017 Aug;71(4):256-260. doi: 10.5455/medarh.2017.71.256-260.
2
The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.p57(KIP2) 免疫组化染色和基因分型检测在葡萄胎诊断中的应用。
Pathol Res Pract. 2011 Aug 15;207(8):498-504. doi: 10.1016/j.prp.2011.06.004. Epub 2011 Jul 20.
3
Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.使用p57免疫组织化学和分子基因分型对葡萄胎进行诊断和亚分类:在常规和会诊实践环境中的验证及前瞻性分析,并开发算法方法
Am J Surg Pathol. 2009 Jun;33(6):805-17. doi: 10.1097/PAS.0b013e318191f309.
4
Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.葡萄胎的诊断可重复性:辅助技术(p57 免疫组化和分子基因分型)可提高形态学诊断。
Am J Surg Pathol. 2012 Mar;36(3):443-53. doi: 10.1097/PAS.0b013e31823b13fe.
5
"While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.“有 p57,就有希望。” 早孕期流产诊断的过去和现在:诊断困境与算法途径。综述。
Placenta. 2021 Dec;116:31-37. doi: 10.1016/j.placenta.2021.02.010. Epub 2021 Feb 25.
6
P57 immunohistochemical marker as a diagnostic tool for cases of hydatidiform moles in a tertiary health facility in Southwestern Nigeria.P57 免疫组化标志物在尼日利亚西南部一家三级医疗机构葡萄胎病例中的诊断工具。
Niger Postgrad Med J. 2020 Oct-Dec;27(4):331-335. doi: 10.4103/npmj.npmj_231_20.
7
Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.葡萄胎的诊断可重复性:辅助技术(p57 免疫组化和分子基因分型)提高了近期受训和经验丰富的妇科病理学家的形态学诊断能力。
Am J Surg Pathol. 2012 Dec;36(12):1747-60. doi: 10.1097/PAS.0b013e31825ea736.
8
Accuracy of p57 compared with genotyping for the diagnosis of complete hydatidiform mole: protocol for a systematic review and meta-analysis.与基因分型相比,p57在完全性葡萄胎诊断中的准确性:系统评价与荟萃分析方案
Syst Rev. 2016 Oct 4;5(1):169. doi: 10.1186/s13643-016-0349-7.
9
p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.水囊状胎块中 p57 不一致的绒毛:70 例临床病理研究。
Hum Pathol. 2020 Jul;101:18-30. doi: 10.1016/j.humpath.2020.04.011. Epub 2020 May 6.
10
[Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].[P57KIP2免疫组化及流式细胞术在葡萄胎诊断中的作用]
Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):580-4.

引用本文的文献

1
Molecular Basis of Hydatidiform Moles-A Systematic Review.葡萄胎的分子基础——系统综述。
Int J Mol Sci. 2024 Aug 10;25(16):8739. doi: 10.3390/ijms25168739.
2
Outcomes of Gestational Trophoblastic Disease Management: A Single Centre Review.妊娠滋养细胞疾病管理的结局:单中心回顾。
Medicina (Kaunas). 2023 Sep 8;59(9):1632. doi: 10.3390/medicina59091632.
3
Expression of p57 immunomarker in the classification and differential diagnosis of partial and complete hydatidiform moles.p57免疫标志物在部分性和完全性葡萄胎分类及鉴别诊断中的表达

本文引用的文献

1
Hydatidiform Moles: Genetic Basis and Precision Diagnosis.葡萄胎:遗传学基础与精准诊断。
Annu Rev Pathol. 2017 Jan 24;12:449-485. doi: 10.1146/annurev-pathol-052016-100237.
2
Clinical and radiological correlations in patients with gestational trophoblastic disease.妊娠滋养细胞疾病患者的临床与影像学相关性
Radiol Bras. 2016 Jul-Aug;49(4):241-250. doi: 10.1590/0100-3984.2015.0073.
3
Accuracy of p57 compared with genotyping for the diagnosis of complete hydatidiform mole: protocol for a systematic review and meta-analysis.
J Lab Physicians. 2019 Jul-Sep;11(3):270-274. doi: 10.4103/JLP.JLP_130_19.
与基因分型相比,p57在完全性葡萄胎诊断中的准确性:系统评价与荟萃分析方案
Syst Rev. 2016 Oct 4;5(1):169. doi: 10.1186/s13643-016-0349-7.
4
Sonographic diagnosis of partial versus complete molar pregnancy: A reappraisal.部分性与完全性葡萄胎妊娠的超声诊断:重新评估
J Clin Ultrasound. 2017 Feb;45(2):72-78. doi: 10.1002/jcu.22410. Epub 2016 Oct 3.
5
Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age.调整年龄后种族/族裔对完全性和部分性葡萄胎风险的影响。
Gynecol Oncol. 2016 Oct;143(1):73-76. doi: 10.1016/j.ygyno.2016.07.117. Epub 2016 Jul 30.
6
Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11.异常绒毛形态酷似葡萄胎,与染色体3、7、8的父源性三体及染色体11的单亲二体相关。
Diagn Pathol. 2016 Feb 4;11:20. doi: 10.1186/s13000-016-0471-9.
7
Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study.20 年来基于人群的研究中妊娠滋养细胞疾病发病率的变化趋势。
Gynecol Oncol. 2016 Jan;140(1):70-5. doi: 10.1016/j.ygyno.2015.11.014. Epub 2015 Nov 14.
8
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?过去三十年中新英格兰滋养细胞疾病中心完全性葡萄胎表现的变化:早期诊断是否会改变妊娠滋养细胞肿瘤的风险?
Gynecol Oncol. 2015 Jul;138(1):46-9. doi: 10.1016/j.ygyno.2015.05.002. Epub 2015 May 10.
9
The involvement of the trans-generational effect in the high incidence of the hydatidiform mole in Africa.非洲葡萄胎高发中跨代效应的参与情况。
Placenta. 2015 Jan;36(1):48-51. doi: 10.1016/j.placenta.2014.10.017. Epub 2014 Nov 8.
10
The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome.母亲年龄与葡萄胎发生率、化疗风险及后续妊娠结局的关系。
J Obstet Gynaecol. 2013 May;33(4):406-11. doi: 10.3109/01443615.2013.771159.